A water soluble form of the potent p38 (SAPK2a) inhibitor SB202190 (Prod. No. BML-EI294).
Product Details
| Alternative Name: | FHPI . HCl, 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole . HCl |
| |
| Formula: | C20H14FN3O . HCl |
| |
| MW: | 331.3 . 36.5 |
| |
| CAS: | 350228-36-3 |
| |
| Purity: | ≥96% (HPLC) |
| |
| Identity: | Determined by 1H-NMR. |
| |
| Appearance: | Yellow solid. |
| |
| Solubility: | Soluble in water, methanol or DMSO. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | -20°C |
| |
| Handling: | Protect from light. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Establishment of bovine 3D enteroid-derived 2D monolayers: K.M. Sutton, et al.; Vet. Res.
53, 15 (2022),
Abstract;
Luteolin Attenuates IL-1 β-Induced THP-1 Adhesion to ARPE-19 Cells via Suppression of NF- κ B and MAPK Pathways: W. Huang, et al.; Mediators Inflamm.
2020, 9421340 (2020),
Abstract;
Full Text
Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy: M. Grzmil, et al.; Cell. Signal.
28, 1412 (2016),
Application(s): Cell culture,
Abstract;
Related Products
